KB Financial Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$13K Hold
31
﹤0.01% 374
2023
Q2
$14K Sell
31
-345
-92% -$159K ﹤0.01% 375
2023
Q1
$173K Buy
376
+52
+16% +$24.7K 0.05% 173
2022
Q4
$166K Sell
324
-69
-18% -$35K 0.06% 180
2022
Q3
$179K Buy
393
+60
+18% +$28.7K 0.06% 167
2022
Q2
$161K Sell
333
-214
-39% -$106K 0.06% 169
2022
Q1
$268K Buy
547
+54
+11% +$24.7K 0.07% 156
2021
Q4
$229K Buy
+493
New +$207K 0.07% 168
2021
Q3
Sell
-197
Closed -$75K 290
2021
Q2
$75K Sell
197
-1
-0.5% -$382 0.03% 229
2021
Q1
$71K Buy
+198
New +$63.7K 0.03% 234

Other funds holding ELV

KB Financial Partners's ELV Position: Q3 2023 in Review

KB Financial Partners held its Elevance Health (ELV) position steady in Q3 2023 at 31 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #374.

KB Financial Partners first reported a position in ELV in Q1 2021 and has held it in 10 quarters since. The position peaked at $268K in Q1 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • KB Financial Partners held 31 shares of Elevance Health worth $13K as of Q3 2023.
  • KB Financial Partners left its Elevance Health share count unchanged in Q3 2023.
  • Elevance Health made up ﹤0.01% of KB Financial Partners's portfolio in Q3 2023, its #374 holding.
  • KB Financial Partners first reported a position in Elevance Health in Q1 2021 and has held it in 10 quarters since.
  • KB Financial Partners's Elevance Health position peaked at $268K in Q1 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.